Tianfeng Wang

Harbin Medical University

H指数:22

被引数:1,555

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of immune characteristic biomarkers and therapeutic targets in cuproptosis for sepsis by integrated bioinformatics analysis and single-cell RNA sequencing analysis

整合生物信息学分析和单细胞RNA测序分析鉴定败血症的免疫特征性生物标志物和治疗靶点

HELIYON

IF3.6

2024-03-013

OAAI

Identification of immune-related lncRNA in sepsis by construction of ceRNA network and integrating bioinformatic analysis

BMC GENOMICS

IF3.7

2023-08-248

OAAI

Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial (vol 9, 54, 2023)

NPJ BREAST CANCER

IF7.6

2023-07-240

Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial

NPJ BREAST CANCER

IF7.6

2023-06-213

RNA2Immune: A Database of Experimentally Supported Data Linking Non-coding RNA Regulation to The Immune System

GENOMICS PROTEOMICS & BIOINFORMATICS

IF7.9

2022-05-178

OAAI

Pathological response-guided postoperative treatment strategy for positive HR/negative HER2 and positive lymphnodes breast cancer patients with non-responsive pathological results to neoadjuvant chemotherapy

CANCER RESEARCH

IF16.6

2022-02-150

PRE

Competitive endogenous RNA network and pathway-based analysis of LncRNA single-nucleotide polymorphism in myasthenia gravis

SCIENTIFIC REPORTS

IF3.9

2021-12-148

OAAI

Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2021-11-1814

OAAI

Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in BRCA1 Mutation

CANCER RESEARCH

IF16.6

2021-03-1653

Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival inBRCA1/2-mutated triple-negative breast cancer

卡铂联合蒽环类-紫杉类新辅助化疗对brca1/2突变三阴性乳腺癌生存率的影响

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2020-08-1318

OAAI

Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score adjustment method

BREAST CANCER RESEARCH AND TREATMENT

IF3

2020-07-2616

PREAI

BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2020-02-2220

OAAI

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients

在未经选择的中国乳腺癌患者的大型队列中，BRCA1和BRCA2突变携带者的对侧乳腺癌风险

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2020-02-1821

OAAI

Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2019-06-0420

OAAI

MicroRNAs and nervous system diseases: network insights and computational challenges

BRIEFINGS IN BIOINFORMATICS

IF7.7

2019-04-0534

PREAI

Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China

中国BRCA1和BRCA2突变的原发性浸润性乳腺癌保乳术后患侧乳腺肿瘤复发的风险

BREAST CANCER RESEARCH AND TREATMENT

IF3

2019-03-2026

PREAI

Global pathway view analysis of microRNA clusters in myasthenia gravis

重症肌无力microRNA簇的全球通路视图分析

MOLECULAR MEDICINE REPORTS

IF3.5

2019-01-104

Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients

BREAST CANCER RESEARCH AND TREATMENT

IF3

2019-01-0318

PREAI

Impact of clinical and pathological factors on local recurrence after breast-conserving treatment: CT-based localization for a tumor bed boost yielded better local control when compared with a surgical scar

JOURNAL OF CANCER

IF3.2

2019-01-012

OAAI

The long noncoding RNA MALAT-1 functions as a competing endogenous RNA to regulate MSL2 expression by sponging miR-338-3p in myasthenia gravis

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2018-10-2630

PREAI

Tianfeng Wang

个人简介

教育背景

工作经历

荣誉奖项

研究方向